(Q28749625)

English

Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice

scientific article (publication date: 19 August 2010)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice (English)

0 references

0 references

object named as

Hsin-Wei Chen

12

0 references

object named as

Ming-Hsi Huang

1

0 references

author name string

Su-Chen Lin

2

0 references

Chia-Hsin Hsiao

3

0 references

Hsin-Ju Chao

4

0 references

Hung-Ren Yang

5

0 references

Chien-Chun Liao

6

0 references

Po-Wei Chuang

7

0 references

Huang-Pi Wu

8

0 references

Chiung-Yi Huang

9

0 references

Chih-Hsiang Leng

10

0 references

Shih-Jen Liu

11

0 references

Ai-Hsiang Chou

13

0 references

Alan Yung-Chih Hu

14

0 references

Pele Chong

15

0 references

language of work or name

0 references

publication date

19 August 2010

0 references

0 references

5

0 references

8

0 references

e12279

0 references

copyright license

Creative Commons Attribution 4.0 International

19 August 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

16 March 2017

Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Molecular and cellular signatures of human vaccine adjuvants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Safety of MF59 adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

20 June 2018

Boosting our best shot

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012279

21 January 2018

Boosting vaccine power.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924384

27 November 2018

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20808862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010

1 reference

https://pubmed.ncbi.nlm.nih.gov/20808862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aluminum compounds as vaccine adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20808862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20808862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of adjuvant-active nonionic block copolymers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20808862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0012279

0 references

2010PLoSO...512279H

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28749625&oldid=1870094612"